People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Biotechnology, Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NantBio, Inc. | — | Biotechnology | Series C | $180.1M | $856.7M | 2023 |
| Tensorcom, Inc. | — | Other Technology | Series A | $23.6M | $128.0M | 2010 |
| ITA Partners, Inc. | — | Other Health Care | Series A | $10.1M | $102.7M | 2009 |
| Adeptence, LLC | — | Other Technology | Series A | $5.8M | $160.9M | 2014 |
Charles Kenworthy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Kenworthy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Soon-Shiong | 3 | 16 |
| Orang Dialameh | 2 | 3 |
| Ismail Lakkis | 2 | 3 |
| Christian Zapf | 2 | 2 |
| Hock Law | 2 | 2 |
| Sanjay Gupta | 1 | 6 |
| Patrick Shoon-Shiong | 1 | 3 |
| Douglas Reed Maughan | 1 | 3 |
| Patrick Soon-Shiong, M.D. | 1 | 2 |
| Eduardo Beruff | 1 | 1 |
| John Bartlett | 1 | 1 |
| Chris Olivia, M.D. | 1 | 1 |
| Joel Balbien | 1 | 1 |
| James Banaag | 1 | 1 |
| Robert Coomis, M.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.